{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:57:49Z","timestamp":1791046669150,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.jbspin.2005.10.004","type":"journal-article","created":{"date-parts":[[2005,10,26]],"date-time":"2005-10-26T11:24:07Z","timestamp":1130325847000},"page":"456-460","source":"Crossref","is-referenced-by-count":56,"title":["The RATIO observatory: French registry of\u00a0opportunistic infections, severe bacterial infections, and\u00a0lymphomas complicating anti-TnF\u03b1 therapy"],"prefix":"10.1016","volume":"72","author":[{"given":"Florence","family":"Tubach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Salmon-C\u00e9ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Ravaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mariette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2005.10.004_bib1","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Choy","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2005.10.004_bib2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.40.4.443","article-title":"Tumor necrosis factor and Crohn\u2019s disease","volume":"40","author":"van Deventer","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.jbspin.2005.10.004_bib3","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/art.1780310816","article-title":"Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum","volume":"31","author":"Saxne","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2005.10.004_bib4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/rheumatology\/39.4.432","article-title":"Tumour necrosis factor alpha and its soluble receptors in juvenile chronic arthritis","volume":"39","author":"Rooney","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2005.10.004_bib5","first-page":"522","article-title":"Interleukin 1beta (IL-1beta), IL-10, tumor necrosis factor-alpha, and cellular proliferation index in peripheral blood mononuclear cells in patients with ankylosing spondylitis","volume":"29","author":"Vazquez-Del","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2005.10.004_bib6","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1365-2133.2005.06440.x","article-title":"Overexpression of tumour necrosis factor-alpha-converting enzyme in psoriasis","volume":"152","author":"Kawaguchi","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jbspin.2005.10.004_bib7","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor Necrosis factor trial in rheumatoid arthritis with Concomitant Therapy Study Group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2005.10.004_bib8","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(00)03239-6","article-title":"Crohn\u2019s disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms","volume":"356","author":"Van den Bosch","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2005.10.004_bib9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa012664","article-title":"Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha","volume":"346","author":"Gorman","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2005.10.004_bib10","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","article-title":"Etanercept as monotherapy in patients with psoriasis","volume":"349","author":"Leonardi","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2005.10.004_bib11","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S1286-4579(00)01282-X","article-title":"The divergent role of tumor necrosis factor receptors in infectious diseases","volume":"2","author":"Schluter","year":"2000","journal-title":"Microbes Infect."},{"key":"10.1016\/j.jbspin.2005.10.004_bib12","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1128\/IAI.63.9.3674-3682.1995","article-title":"Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections","volume":"63","author":"Mastroeni","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jbspin.2005.10.004_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","article-title":"Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management","volume":"3","author":"Gardam","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jbspin.2005.10.004_bib14","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1053\/gast.2001.28702","article-title":"Infliximab induces apoptosis in monocytes from patients with chronic active Crohn\u2019s disease by using a caspase-dependent pathway","volume":"121","author":"Lugering","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbspin.2005.10.004_bib15","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/ard.2004.024737","article-title":"Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety","volume":"63","author":"Hyrich","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2005.10.004_bib16","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2005.10.004_bib17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/ard.62.8.791","article-title":"French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers","volume":"62","author":"Mariette","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2005.10.004_bib18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/art.10758","article-title":"Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents","volume":"48","author":"Slifman","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2005.10.004_bib19","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/art.10583","article-title":"Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept","volume":"46","author":"Lee","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2005.10.004_bib20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/502250","article-title":"Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: a possible healthcare-associated case?","volume":"24","author":"De Rosa","year":"2003","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.jbspin.2005.10.004_bib21","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/rheumatology\/41.8.951","article-title":"Pneumocystis carinii pneumonia following a second infusion of infliximab","volume":"41","author":"Tai","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2005.10.004_bib22","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1086\/425123","article-title":"Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis","volume":"39","author":"Haerter","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jbspin.2005.10.004_bib23","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2141.2000.02404.x","article-title":"Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells","volume":"111","author":"Clodi","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jbspin.2005.10.004_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4049\/jimmunol.156.2.507","article-title":"A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death","volume":"156","author":"Lens","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbspin.2005.10.004_bib25","first-page":"20","article-title":"Hematopoietic malignancies in rheumatoid arthritis. Lymphoma risk and characteristics following TNF-antagonists","volume":"20","author":"Askling","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2005.10.004_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/ard.2004.030528","article-title":"Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas","volume":"64","author":"Geborek","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2005.10.004_bib27","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/art.20311","article-title":"Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2005.10.004_bib28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/ard.2005.035311","article-title":"Risk of lymphoma in patients with RA treated with anti-TNF-alpha agents","volume":"64","author":"Franklin","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl","key":"10.1016\/j.jbspin.2005.10.004_bib29","first-page":"S48","article-title":"Assuming the safety of biologic therapies in rheumatoid arthritis: the challenge of study design","volume":"32","author":"Hyrich","year":"2005","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2005.10.004_bib30","first-page":"79","article-title":"The quantification of drug risks in practice","volume":"45","author":"Lee","year":"1993","journal-title":"WHO Reg. Publ. Eur. Ser."}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X05001636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X05001636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T06:12:50Z","timestamp":1683267170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X05001636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S1297319X05001636"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2005.10.004","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}